Governance

The Board supports the principles of good corporate governance set out in the Financial Reporting Council's UK Corporate Governance Code (and, in respect of the period under review, in the Combined Code on Corporate Governance). Though the Group as an AIM listed company is not required to fully comply with the Corporate Governance Code, the Board is committed to a level of compliance appropriate for a smaller public company.

The Board considers that it has maintained an appropriate level of compliance with the provisions set out in Section 1 of the Combined Code for the year to 31 December 2010 and its revised structure in 2011 maintains a significant independent element with appropriate skills and experience.

Board of Directors

During the year to 31 December 2010, the Board consisted of an Executive Chairman and three Non-executive Directors. On 4 January 2010, Dr. Armstrong resigned as a Non-executive Director and Patrick Regan was appointed as a Non-executive Director. On 10 May 2010, Dr. Vernon resigned as a Non-Executive Chairman and Director. On 9 July 2010, Dr. Noonan resigned as a Non-Executive Director and James Hills was appointed as a Non-Executive Director. On 4 August 2010, Keith Bigsby resigned as Chief Financial Officer and Executive Director.

On joining the Board, all Directors received a full induction and have the opportunity to meet with shareholders at the Annual General Meeting.

Biographies of the current Board members appear on the Board of Directors page. These indicate the high level and range of experience, which enables the Group to be managed effectively. The Board has established three committees in relation to Directors' remuneration and audit matters and nominations to the Board.

The membership of all Board Committees remained unchanged during the year and is set out below:

• Remuneration Committee: Mr. Hills (Chairman) and Mr. Riley.
• Audit Committee: Mr. Riley (Chairman), Mr. Hills and Mr. Regan.
• Nomination Committee: Mr. Reade (Chairman), Mr. Riley and Mr. Hills.

On 4 January 2010, Mr. Reade resigned as Chairman of the Remuneration Committee with his appointment as Executive Chairman and Dr. Noonan became the new Chairman of the Remuneration Committee. Dr. Noonan resigned as Chairman of the Remuneration Committee on 9 July 2010 and Mr. Hills became the new Chairman of the Remuneration Committee. Mr. Riley was appointed to the Remuneration Committee on 9 July 2010. Dr. Vernon resigned as Chairman of the Nominations Committee on 4 January 2010 and was replaced by Mr. Reade. Mr. Hills was appointed to the Nominations Committee on 9 July 2010. Dr. Vernon resigned from the Audit Committee on 10 May 2010 with his resignation from the Board and was replaced by Mr. Hills on 9 July 2010.

The Board is responsible to the shareholders for the proper management of the Group. The Board has adopted a formal schedule of matters specifically reserved for the Board's decision that covers key areas of the Group's affairs including overall responsibility for the business and commercial strategy of the Group, policy on corporate governance issues, review of trading performance and forecasts, the approval of major transactions and the approval of the interim management and financial statements, annual report and financial statements and operating and capital expenditure budgets.

The Executive Chairman leads the Board in the determination of its strategy and in the achievement of its objectives. The Executive Chairman is responsible for organizing the business of the Board, ensuring its effectiveness and setting its agenda. The Executive Chairman facilitates the effective contribution of Non-executive Directors and constructive relations between Executive and Non-executive Directors, ensuring Directors receive accurate, timely and clear information. The Executive Chairman gives feedback to the Board on issues raised by major shareholders.

The Board evaluates its own effectiveness on an annual basis by measuring performance against a standard set of objectives assessed by each member of the Board.

The Board delegates the day to day responsibility for managing the Group to the Executive Chairman who is accountable to the Board for the financial and operational performance of the Group.

The Group regarded J. Hills and B.M. Riley as independent Non-executive Directors during the year ended 31 December 2010. Since the appointment of Mr. Reade as Executive Chairman, he ceased to be regarded as independent. The Independent Directors constructively challenge and help develop proposals on strategy, and bring strong independent judgment, knowledge and experience to the Board's deliberations. The Independent Directors are of sufficient calibre and number that their views carry significant weight in the Board's decision making. B.M. Riley is the Senior Independent Director. As Senior Independent Director, he is available to shareholders if they have concerns where contact through the normal channels of Executive Chairman or Chief Financial Officer has failed to resolve matters or for which such contact would be inappropriate.

The Board has five regularly scheduled meetings annually with additional meetings to discuss strategy and other pertinent issues organized as necessary during the year.

Prior to each meeting the Board members receive copies of the management accounts and are furnished with information in a form and quality appropriate for it to discharge its duties concerning the state of the business and performance compared to plan. All Directors have access to the services of the Group Secretary and may take independent professional advice at the Group's expense in the furtherance of their duties.

The Non-executive Directors meet after each Board meeting without the Executive Chairman being present.

The attendance of individual Directors at Board meetings during the year is set out in the table below:

	Number of Meetings	Meetings Attended
G.N. Vernon	5	5
K.E. Bigsby	9	9
A.J. Reade	14	14
B.M. Riley	14	14
K.D. Noonan	8	8
J. Hills	6	6
P. Regan	14	13

At the forthcoming Annual General Meeting Mr. Hills will offer himself for election as a director for a term of three years in accordance with the provisions of the Company's Certificate of Incorporation.

Board Committees

The Remuneration Committee is responsible for establishing and monitoring appropriate levels of remuneration and individual remuneration packages for Executive Directors. No Director is involved in deciding his own remuneration. The report of the Remuneration Committee is set out in the 2010 Annual Report.

The attendance of individual Directors at Remuneration Committee meetings during the year is set out in the table below:

	Number of Meetings	Meetings Attended
J. Hills	2	2
B.M. Riley	2	2

The Group has an Audit Committee, whose responsibilities include reviewing the scope of the audit and audit procedures, the format and content of the audited financial statements and interim reports, including the notes and the accounting principles applied. The Audit Committee also reviews internal control, including internal financial control, in conjunction with the Board. The Audit Committee will also review any proposed change in accounting policies and any recommendations from the Group's auditors regarding improvements to internal controls and the adequacy of resources within the Group's finance function. The Audit Committee advises the Board on the appointment of external auditors and on their remuneration both for audit and non-audit work, and discusses the nature, scope and results of the external audit with the external auditors. The Audit Committee keeps under review the cost effectiveness and the independence and objectivity of the external auditors.

All Directors may attend audit committee meetings. At least twice a year representatives of the Group's auditors have an opportunity to meet the Audit Committee at which time they also have the opportunity to discuss matters without any Executive Director being present.

The Audit Committee monitors fees paid to the auditors for non-audit work and evaluates on a case by case basis whether it should put the requirement for non-audit services out to tender. The Group's auditors, Grant Thornton LL P, have not been instructed to carry out non-audit work during the year. Other firms of advisors were employed during the year for tax compliance services.

A “whistle blowing” policy has been implemented whereby employees may contact the Chairman of the Audit Committee on a confidential basis.

The attendance of individual Directors at Audit Committee meetings during the year is set out in the table below:

	Number of Meetings	Meetings Attended
B.M. Riley	3	3
J. Hills	2	2
K.D. Noonan	1	1
By invitation:
K.E. Bigsby	1	1
A.J. Reade	3	3
P. Regan	3	2

The Nomination Committee is responsible for considering and making recommendations concerning the composition of the Board, including proposed appointees to the Board, whether to fill vacancies that may arise or to change the number of Board members. The appointments during the year did not involve open advertising.

The attendance of individual Directors at Nomination Committee meetings during the year is set out in the table below:

	Number of Meetings	Meetings Attended
A.J. Reade (Chairman)	1	1
B.M. Riley	1	1
By invitation:
P. Regan	1	1

Internal Control and Risk Management

The Directors acknowledge that they are responsible for establishing and maintaining the Group's system of internal control and reviewing its effectiveness. The Group is small and the Directors are closely involved in the management of the business. At the beginning of the financial year we identified the key risks that the Group faced during the financial year. The Board has since reviewed these risks as part of the strategic planning exercise, considering the likelihood of the risk occurring and the potential impact on the business. The Board will continue to review and update the risk management process on an ongoing basis. No significant weaknesses or failings were identified, however, the internal controls are designed to manage rather than eliminate the risk of failure to achieve business objectives and the Board recognizes that any system can only provide reasonable and not absolute assurance against material misstatement or loss.

The Group operating procedures include a comprehensive system for reporting financial and non-financial information to the Directors.

The planning system produces a rolling three year strategic plan annually. The first year of the three year plan is a proposed operating budget, phased monthly. These are approved by the Board and forecast updates are carried out quarterly. The financial projections include income statement, balance sheet and cash flows.

The Board reviews the actual financial results versus budget and forecast together with other management reports containing non-financial information.

Schedules of financial authority limits detailing management authority limits for commitments in respect of sales orders, capital and operating expenditure are circulated to relevant employees and updated at least annually.

The Board considers that there have been no weaknesses in internal financial controls that have resulted in any material losses, contingencies or uncertainties requiring disclosure in the financial statements.

The Executive Chairman ensures that directors take independent professional advice as required at the Group's expense in appropriate circumstances and all members of the Board have access to the advice of the Group Secretary.

Going Concern

The Company has produced monthly forecasts to the end of 2013 and based upon cash expected to be received through existing contracts, new contracts to be closed and the ability to control costs as a result of the Company's cost minimization program, with existing cash on hand and cash received from a share placings in 2010, the Directors believe that the Company will have sufficient cash to meet its working capital needs through the next twelve months. For this reason the Company continues to adopt the going concern basis.

On 26 May 2011, the New York Supreme Court, Appellate Division of New York County issued a ruling entering judgment in favour of the Company and against Molecular and dismissing Molecular's complaint in its entirety. Molecular may choose to appeal the ruling with the Court of Appeals (New York's highest court) in which case the Company will continue to vigorously defend itself. As a result, the Company has not recorded any liability. If Molecular Securities, Inc. were to prevail in the litigation there could be a material adverse effect upon the Group's working capital and the Company might have insufficient funds to meet such a claim.

Internal Audit

The Group does not have an internal audit function. However, the Audit Committee reviews annually the need for such a function and has done so during the year. The current conclusion of the Board is that it is not necessary given the modest scale and lack of complexity of the Group's activities.

Shareholder Communication

It is the Group's policy to involve its shareholders in the affairs of the Group and to give them the opportunity at the Annual General Meeting to ask questions about the Group's activities. This process enables the views of shareholders to be communicated to the Board. In addition, any direct enquiries are dealt with by the Group Secretary and communicated as appropriate to the Board. Other than in exceptional circumstances, all directors, including those newly appointed, attend the Annual General Meeting of the Group, and make themselves available for introductions and answering shareholders' questions. Established procedures ensure the timely release of price sensitive information and the publication of financial results and regulatory financial statements. The Group also maintains a website, www.tyratech.com, which incorporates corporate, financial, product information and news.

 

Documents

Amended and restated bylaws - adopted 23 May 2007 and amended of 19 May 2010

Certificate of Amendment - dated 19 May 2010

Certificate of amendment - dated 18 August 2008